We are live on ! Find out more
RVLP

RVL Pharmaceuticals plc Ordinary Shares
RVLP

Delisted

RVLP was delisted on the 20th of October, 2023.

Back to rankings

62 hedge funds and large institutions have $25.6M invested in RVL Pharmaceuticals plc Ordinary Shares in 2020 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

117% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 12

24% more funds holding

Funds holding: 50 → 62 (+12)

4% more capital invested

Capital invested by funds: $24.6M → $25.6M (+$959K)

Holders
62
Holders Change
+12
Holders Change %
+24%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
26
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SS
Sunbelt Securities
Texas
+$5.62M
2
SCM
Sio Capital Management
New York
+$3.06M
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.73M
4
Millennium Management
Millennium Management
New York
+$2.23M
5
Marshall Wace
Marshall Wace
United Kingdom
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
OAM
Oxford Asset Management
United Kingdom
-$601K
2
Morgan Stanley
Morgan Stanley
New York
-$390K
3
PAM
Panagora Asset Management
Massachusetts
-$322K
4
Walleye Capital
Walleye Capital
New York
-$217K
5
AIM
Alambic Investment Management
California
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
SS
1
Sunbelt Securities
Texas
$5.27M +$5.62M +1,054,441 New
BlackRock
2
BlackRock
New York
$3.59M +$257K +48,311 +4%
Renaissance Technologies
3
Renaissance Technologies
New York
$3.25M +$2.73M +512,595 +100%
SCM
4
Sio Capital Management
New York
$1.83M +$3.06M +575,000 New
Millennium Management
5
Millennium Management
New York
$1.33M +$2.23M +418,646 New
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$1.05M +$823K +154,541 +89%
Marshall Wace
7
Marshall Wace
United Kingdom
$1.03M +$1.46M +274,739 +543%
WCM
8
Wedge Capital Management
North Carolina
$965K +$534K +100,219 +49%
AllianceBernstein
9
AllianceBernstein
Tennessee
$757K +$1.27M +238,090 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$719K +$640K +120,259 +113%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$648K +$352K +66,058 +48%
Squarepoint
12
Squarepoint
New York
$551K +$580K +108,962 +169%
State Street
13
State Street
Massachusetts
$523K +$101K +19,021 +13%
Arrowstreet Capital
14
Arrowstreet Capital
Massachusetts
$461K +$456K +85,682 +144%
Northern Trust
15
Northern Trust
Illinois
$413K +$163K +30,552 +31%
AQR Capital Management
16
AQR Capital Management
Connecticut
$351K +$588K +110,447 New
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$293K +$56.5K +10,600 +13%
Russell Investments Group
18
Russell Investments Group
United Kingdom
$277K +$466K +87,501 New
Charles Schwab
19
Charles Schwab
California
$208K +$143K +26,778 +70%
Citadel Advisors
20
Citadel Advisors
Florida
$190K +$319K +59,823 New
MAM
21
Martingale Asset Management
Massachusetts
$175K +$35.7K +6,700 +14%
AIM
22
Alambic Investment Management
California
$159K -$126K -23,635 -32%
EGM
23
Engineers Gate Manager
New York
$131K +$46.2K +8,679 +27%
OAM
24
Oxford Asset Management
United Kingdom
$123K -$601K -112,827 -74%
MF
25
Magnetar Financial
Illinois
$114K +$191K +35,786 New
1
2 3

RVLP Hedge Fund Activity: Q1 2020 in Review

62 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in RVL Pharmaceuticals plc Ordinary Shares (RVLP) for Q1 2020, worth a combined $25.6M — up 3.9% from $24.6M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new RVLP positions and 7 closed out — a net gain of 12 holders — while 26 added to existing stakes and 12 trimmed.

The largest buyer was Sunbelt Securities, opening a new position worth an estimated $5.62M. The largest seller was Oxford Asset Management, cutting an estimated $601K.

  • 62 institutional investors held RVL Pharmaceuticals plc Ordinary Shares (RVLP) as of Q1 2020, up from 50 in Q4 2019.
  • Funds reported $25.6M of RVL Pharmaceuticals plc Ordinary Shares stock for Q1 2020, up 3.9% quarter-over-quarter.
  • 19 funds opened new RVL Pharmaceuticals plc Ordinary Shares positions in Q1 2020 and 7 closed out, a net change of +12 holders.
  • The largest RVL Pharmaceuticals plc Ordinary Shares buyer in Q1 2020 was Sunbelt Securities, an estimated $5.62M added.
  • The largest RVL Pharmaceuticals plc Ordinary Shares seller in Q1 2020 was Oxford Asset Management, an estimated $601K sold.

Based on aggregated 13F filings for Q1 2020.